Similar articles

• [Active management of patients with Alzheimer disease].

  Derouesné C. Derouesné C. Geriatr Psychol Neuropsychiatr Vieil. 2013 Sep;11(3):273-4. doi: 10.1684/pnv.2013.0420. Geriatr Psychol Neuropsychiatr Vieil. 2013. PMID: 24026129 French. No abstract available.
• Cognitive enhancement in schizophrenia: pharmacological and cognitive remediation approaches.

  Harvey PD, Bowie CR. Harvey PD, et al. Psychiatr Clin North Am. 2012 Sep;35(3):683-98. doi: 10.1016/j.psc.2012.06.008. Epub 2012 Jul 15. Psychiatr Clin North Am. 2012. PMID: 22929873 Free PMC article. Review.
• Effect of donepezil on the continuum of depressive symptoms, mild cognitive impairment, and progression to dementia.

  Panza F, Frisardi V, Capurso C, D'Introno A, Colacicco AM, Chiloiro R, Dellegrazie F, Di Palo A, Capurso A, Solfrizzi V. Panza F, et al. J Am Geriatr Soc. 2010 Feb;58(2):389-90. doi: 10.1111/j.1532-5415.2009.02702.x. J Am Geriatr Soc. 2010. PMID: 20370868 No abstract available.
• [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia].

  Tariska P, Paksy A. Tariska P, et al. Orv Hetil. 2000 May 28;141(22):1189-93. Orv Hetil. 2000. PMID: 10853348 Clinical Trial. Hungarian.
• [Pharmacological treatment of vascular cognitive impairment].

  Bidzan L. Bidzan L. Przegl Lek. 2006;63(3):131-3. Przegl Lek. 2006. PMID: 16969897 Review. Polish.